Summary
Ritter Pharmaceuticals develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Andrew J. Ritter
President and CEO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy